2004 we reported 3 cases of chronic hepatitis B in Crohn's disease (CD) patients from a cohort of 80 patients treated with infliximab. 1 Two patients showed severe reactivation, 1 of whom died. Based on the American Association for the Study of Liver Disease (AASLD) and European guidelines, 2,3 pree
Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate
β Scribed by K. Subramaniam; S. Chitturi; M. Brown; P. Pavli
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 188 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
strong clinical significance for the cause and the mechanism of Crohn's disease. More and more evidence has suggested that gut bacteria play a critical role in the development of inflammatory bowel disease, and Crohn's disease seems to develop in the intestine largely as a result of aberrant interac
Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-β£ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat